Xiaoxi Lu
Overview
Explore the profile of Xiaoxi Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
442
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lu R, Shi Y, Yang M, Yang N, He S, Xin L, et al.
Int Immunopharmacol
. 2023 Jul;
122:110633.
PMID: 37451015
Objective: Whether cyclosporine A (CsA) is a risk factor of kidney injury after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has not been determined. We aim to comprehensively review the correlation...
12.
Chen M, Liu L, Zhang L, Lin Y, Lu X, Yang H, et al.
BMC Health Serv Res
. 2023 Jun;
23(1):652.
PMID: 37331932
Background: Tyrosine kinase inhibitors combined with conventional chemotherapy (CC) in treating Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL) has achieved promising efficacy and safety outcomes. The study was conducted to...
13.
Chen Z, Li S, Zou K, Li H, Zeng L, Lu X, et al.
Front Public Health
. 2022 Nov;
10:980969.
PMID: 36408013
Background: Compared with high-income countries, the survival rate of childhood cancer is lower in low- and middle-income countries. Access to essential anticancer medicines is an indispensable component of pediatric cancer...
14.
Han Y, Lu X, Xiao S, Qin J, Zheng L, Feng Y, et al.
Lupus
. 2022 Nov;
32(1):83-93.
PMID: 36396610
Objective: The study aimed to explore the effect of serum uric acid (SUA) level on the progression of kidney function in systemic lupus erythematosus (SLE) patients. Methods: A total of...
15.
Wang T, Tang Y, Cai J, Wan X, Hu S, Lu X, et al.
J Clin Oncol
. 2022 Nov;
41(9):1670-1683.
PMID: 36346962
Purpose: We determined the safety and efficacy of coadministration of CD19- and CD22-chimeric antigen receptor (CAR) T cells in patients with refractory disease or high-risk hematologic or isolated extramedullary relapse...
16.
Deng X, Shan Y, Meng X, Yu Z, Lu X, Ma Y, et al.
Proc Natl Acad Sci U S A
. 2022 Jul;
119(29):e2205827119.
PMID: 35858338
Heterogeneous bubble nucleation is one of the most fundamental interfacial processes ranging from nature to technology. There is excellent evidence that surface topology is important in directing heterogeneous nucleation; however,...
17.
Chen M, Ni J, Lu X
Front Pediatr
. 2022 Jun;
10:923297.
PMID: 35757138
Acute lymphoblastic leukemia (ALL) presenting with hypercalcemia and osteolytic lesions is rare and unusual in childhood. We report a case of a 13-year-old boy with ALL who presented with intermittent...
18.
Xu Z, Chen J, Meng S, Xu P, Zhai C, Huang F, et al.
Plant Commun
. 2022 Jun;
3(5):100350.
PMID: 35733334
Crop wild relatives are an important reservoir of natural biodiversity. However, incorporating wild genetic diversity into breeding programs is often hampered by reproductive barriers and a lack of accurate genomic...
19.
Yang R, Ai Y, Liu C, Lu X
Front Pediatr
. 2022 Jun;
10:829927.
PMID: 35676895
Aggressive natural killer cell leukemia (ANKL) is a rare malignant tumor, especially uncommon in children. ANKL has very aggressive clinical course and bad prognosis and is usually caused by Epstein-Barr...
20.
Ma Y, Lu X, Liu H
Front Oncol
. 2022 Mar;
12:836371.
PMID: 35356218
Background: The purpose of this systematic review and meta-analysis was to evaluate the effect of a neutropenic diet and a control diet on infection and mortality rates in oncology patients...